echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetologia: Flash monitor is associated with improvement of glycosylated hemoglobin level and DKA rate in patients with type 1 diabetes

    Diabetologia: Flash monitor is associated with improvement of glycosylated hemoglobin level and DKA rate in patients with type 1 diabetes

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Purpose/Assumption: We evaluated the actual impact of the use of the flash monitor (FM) on the level of HbA1c, diabetic ketoacidosis (DKA) and the incidence of severe hospitalized hypoglycemia (SHH) in Scottish type 1 diabetic patients , And the incidence of severe hypoglycemia in different social and demographic strata in this population
    .

    We assessed the actual impact of the use of the flash monitor (FM) on the levels of HbA1c, diabetic ketoacidosis (DKA) and severe hospitalized hypoglycemia (SHH) in Scottish type 1 diabetic patients, as well as this population The incidence of severe hypoglycemia in different social and demographic strata in China
    .


    Methods: This study used retrospective, observational, and registration studies, using the National Diabetes Registry, and found 14,682 people who used FM at any time from 2014 to 2020
    .


    After the start of FM, the changes in the human body of HbA1c from the baseline were simulated using a linear mixed model, which also considered the trajectory of the human body before exposure


    Results: By mid-2020, the proportion of people who have used FM is 45.
    9%, and there are big differences in age and socioeconomic status: 64.
    3% of children under 13 years old, 32.
    7% of children 65 years or older, respectively; the poorest quintiles are respectively They are 54.
    4% and 36.
    2%
    .


    Overall, in the second year after the start of FM, the median change of glycosylated hemoglobin in the body is −2.


    Figure 1 Compared with the baseline in HbA1, the change in the coverage time of HbA1 with and without FM exposure in humans starting from FM
    .


    The data is the median (IQR)


    Figure 1 Compared with the baseline in HbA1, the change in the coverage time of HbA1 with and without FM exposure in humans starting from FM


    Figure 2 The estimated fold change (95% CI) of HbA1c in the first year after the start of FM, compared with the pre-exposure level, adjusted according to the pre-exposure trend, baseline HbA1c, age, gender, and diabetes course, and according to the age at the start of FM Stratified by segment (A), gender (B), SIMD quintile (C), previously used pump (D), status of previously completed diabetes education program (E), and early adopter status (F)

    Figure 2 The estimated fold change (95% CI) of HbA1c in the first year after the start of FM, compared with the pre-exposure level, adjusted according to the pre-exposure trend, baseline HbA1c, age, gender, and diabetes course, and according to the age at the start of FM Stratified by segment (A), gender (B), SIMD quintile (C), previously used pump (D), status of previously completed diabetes education program (E), and early adopter status (F)

    Figure 3 The incidence of crude DKA events (95% CI) of FM users before and after the start of FM, based on baseline HbA1c (A), age at FM start (B), gender (C), SIMD quintile (D), Prior use of the pump (E), previously completed diabetes education program status (F), and early adopter status (G) stratified
    .


    Py, person/year

    Figure 3 The incidence of crude DKA events (95% CI) of FM users before and after the start of FM, based on baseline HbA1c (A), age at FM start (B), gender (C), SIMD quintile (D), Prior use of the pump (E), previously completed diabetes education program status (F), and early adopter status (G) stratified


    The initiation of FM is associated with a clinically important reduction in HbA1c and a significant reduction in the DKA rate


    Jeyam A, Gibb FW, McKnight JA,et al.


    Flash monitor initiation is associated with improvements in HbA levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.